CAJ | 학술논문

目的：研究植入式导管药盒系统（PCS）在肝癌介入治疗中的应用价值。方法：229例介入治疗的原发性肝癌病例按不同介入治疗方法分为TACE组、PCS组和TAI组。对三组疗效和方法进行了对比分析。结果：PCS组缓解率虽然与TAI组无显著差异，但1，2年生存率却明显高于TAI组。但随着时间推移，生存率下降显著，与TAI的差异逐渐缩小，3年生存率两组已无明显差异，而TACE与上述两组的差异却越来越明显。结论：PCS在不能栓塞的肝癌介入治疗中有较好的应用价值。髂外动脉穿刺植入药盒优于股动脉及锁骨下动脉法。
목적：연구식입식도관약합계통（PCS）재간암개입치료중적응용개치。방법：229례개입치료적원발성간암병례안불동개입치료방법분위TACE조、PCS조화TAI조。대삼조료효화방법진행료대비분석。결과：PCS조완해솔수연여TAI조무현저차이，단1，2년생존솔각명현고우TAI조。단수착시간추이，생존솔하강현저，여TAI적차이축점축소，3년생존솔량조이무명현차이，이TACE여상술량조적차이각월래월명현。결론：PCS재불능전새적간암개입치료중유교호적응용개치。가외동맥천자식입약합우우고동맥급쇄골하동맥법。
Objective:To evaluate the applied value of the port and catheterconnecting system(PCS)in interventional treatment of hepatocarcinoma.Methods:Based on different interventional methods,all the 229 cases with primary hepatocarcinoma were divided into three groups:group TACE which were treated by chemoterapy and embolization,group PCS they managed with percutaneous femoral artery implantable reservior port and catheter connecting system;and group TAI which were treated with routine hepatic transarterial chemotherapy alone.Their curative effects and managing methods were analyzed.Results:The remission rate in group PCS was not any different as TAI,but the survival rate of 1 or 2 years in PCS was remarkably higher than those of group TAI (P＜0.01 orP＜0.05),the survival rate of 3 years in group PCS was not significantly different from that of group TAI(P＞0.05),but in group TACE there were remarkably different from the other two groups with the time detayes.Conclusion:PCS is of highly value in treating hepatocarcinoma which can not be treated by embolism,The method of PCS through external iliac artery puncture is superior to that through femoral artery and subclavian artery puncture.